{"Abstract": [0], "Tumor": [1], "drug": [2, 46, 62, 124], "resistance": [3, 47], "emerges": [4], "from": [5], "the": [6, 16, 20, 31, 45, 53, 67], "interaction": [7], "of": [8, 19, 30, 48], "two": [9], "critical": [10], "factors:": [11], "tumor": [12, 21, 39, 61, 108, 118, 123], "cellular": [13], "heterogeneity": [14], "and": [15, 93, 121], "immunosuppressive": [17], "nature": [18], "microenvironment": [22], "(TME).": [23], "Tumor-associated": [24], "macrophages": [25], "(TAMs)": [26], "constitute": [27], "essential": [28, 36], "components": [29], "TME.": [32], "M2-like": [33, 56, 75, 104, 113], "TAMs": [34, 57, 76, 105, 114], "are": [35, 72], "in": [37, 77], "facilitating": [38], "metastasis": [40], "as": [41, 43], "well": [42], "augmenting": [44], "tumors.": [49], "This": [50], "review": [51], "encapsulates": [52], "mechanisms": [54], "that": [55, 71, 102], "use": [58], "to": [59, 106], "promote": [60], "resistance.": [63, 125], "We": [64], "also": [65], "describe": [66], "emerging": [68], "therapeutic": [69], "strategies": [70], "currently": [73], "targeting": [74, 112], "combination": [78], "with": [79, 83], "other": [80], "antitumor": [81], "drugs,": [82], "some": [84], "still": [85], "undergoing": [86], "clinical": [87], "trial": [88], "evaluation.": [89], "Furthermore,": [90], "we": [91], "summarize": [92], "analyze": [94], "various": [95], "existing": [96], "approaches": [97], "for": [98], "developing": [99], "novel": [100], "drugs": [101], "target": [103], "overcome": [107, 122], "resistance,": [109], "highlighting": [110], "how": [111], "can": [115], "effectively": [116], "stop": [117], "growth,": [119], "metastasis,": [120]}